Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors

Fig. 1

DNA methylation and T2E status. a Principal component (PC) analysis plot based on the 5000 most variable CpG sites in the dataset. b Average DNA methylation level of the same 5000 CpG sites, by genetic location (Illumina annotation). Statistically significant differences are highlighted; *P value <0.05, **<0.01, or ***<0.001

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us